ProfileGDS5822 / ILMN_2674163
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 18% 42% 33% 10% 25% 2% 34% 56% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 112.518
GSM1276600PDAC Late Ablation Control 220.942
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 114.233
GSM1276603PDAC Late Ablation 28.410
GSM1276604PDAC Late Ablation 313.925
GSM1303940PDAC Late Ablation_anti-CTLA4 14.52
GSM1303941PDAC Late Ablation_anti-CTLA4 216.234
GSM1303942PDAC Late Ablation_anti-CTLA4 331.956